Inhalation Sciences: Rights issue outcome

Research Note

2023-05-15

10:35

Redeye comments on ISAB’s rights issue outcome, which was subscribed to approximately 23% in total. However, as the rights issue was guaranteed up to 80%, the company receives around SEK13.7m before issue-relating costs (cSEK3.5m). As we already anticipated a capital raising, the outcome does not render any changes in our fair value range with a base case of SEK17.

GM

Gustaf Meyer

Sign up for free to continue

Already a member?

Sign in

Disclosures and disclaimers

Premium Plan required to unlock

Unlock companies to access

more high quality research.